|Last Price$4.87||Day Change (%)-1.22%|
|Open Price$4.96||Day Change ($)-0.06|
|Day Range4.82–5.13||52-Week Range3.10–7.45|
As of Tue 07/22/2014 03:44 PM EST | USD
Progenics Pharmaceuticals PGNX announced on March 6 that it would backtrack and reformulate the oral version opioid bowel dysfunction drug MNTX to make it more effective. If successful, the firm could file for its approval in late 2009. Our fair value estimate remains unchanged, as we'd already ...